EZH2 and lymphoma: On the other hand, low level of EZH2 or reduced methylation at histone sites catalyzed by PRC2 may be oncogenic, for example, the recurrent Tyr 641 mutations in catalytic EZH2 SET domain, thought to impair activity, occur in two types of lymphomas arising from germinal center B cells [73].